Reports and Briefs on Pharmaceuticals and Healthcare

Published within

« | ... | 41 | 42 | 43 | 44 | 45 | 46 | 47 | 48 | 49 | ... | » »|

Type Product title / description Pub Price
Report
Report

Spain Pharmaceutical Market Overview – Continued stagnation as generics and price cuts erode market value

Overview of the pharmaceutical market in Spain including socioeconomic and demographic trends, regulatory issues, generics and biosimilars analysis, and pharmaceutical market and pharmaceutical company infrastructure analysis.

Published By Datamonitor
11 Oct 2012 $5700
Buy
Report
Report

Stada Arzneimittel AG: PharmaVitae Report

Analysis of Stada Arzneimittel's corporate strategy, marketed portfolio and pipeline potential over 2010-16.

Published By Datamonitor
24 Feb 2012 $5700
Buy
Report
Report

Stakeholder Insight: Acute Leukemias - Reaching the limits of cytotoxic chemotherapy

Primary research-based analysis of the chronic leukemias market. Includes patient segmentation, treatment trends, prescribing influences and brand perception.

Published By Datamonitor
08 Oct 2009 $15200
Buy
Report
Report

Stakeholder Insight: Breast Cancer (Hormone Receptor-Negative) - Triple-negative breast cancer offers a significant opportunity to new market entrants while Herceptin dominates the HER-2-positive market

Primary research-based analysis of the hormone receptor-positive breast cancer market. Includes epidemiology, patient segmentation, treatment trends, and future treatment scenarios. Separate coverage of triple-negative and HER-2-positive subsets.

Published By Datamonitor
03 Nov 2010 $15200
Buy
Report
Report

Stakeholder Insight: Cancer Pain - Physician survey highlights inadequacies in education and treatment

Datamonitor surveyed 180 oncologists, anesthetists, palliative medicine specialists and pain care specialists in the seven major markets to gain insight into cancer pain prevalence, treatment trends and key prescribing influences.

Published By Datamonitor
23 Dec 2009 $15200
Buy
Report
Report

Stakeholder Insight: COPD in Emerging Markets (Brazil, India, China, US) - Key differences in treatment despite standardized guidelines

Datamonitor's survey of 300 respiratory experts in Brazil, India, China and the US addresses increased interest in COPD in the emerging markets. The US is included as a benchmark, providing unique insight and comparisons of COPD market dynamics.

Published By Datamonitor
22 Dec 2010 $15200
Buy
Report
Report

Stakeholder Insight: Epilepsy - Neurologists remain loyal to brands in genericized market

Primary research-based analysis of the epilepsy market, based on a survey of 180 neurologists in the US, Japan, and EU. Includes epidemiology, patient segmentation, treatment trends, perception of key brands, and patient outcomes.

Published By Datamonitor
16 Dec 2010 $15200
Buy
Report
Report

Stakeholder Insight: Gastric Cancer

Explores key issues in the gastric cancer market, including diagnosis and treatment patterns, specific drug regimens used at each line of therapy, key prescribing influences and predicted performance of late-phase pipeline products.

Published By Datamonitor
15 Sep 2010 $15200
Buy
Report
Report

Stakeholder Insight: Hepatitis B & C in Asia - Tapping the opportunity of high prevalence rates in China, Taiwan, South Korea and Turkey

China, Taiwan, South Korea and Turkey represent highly endemic areas for viral Hepatitis, but little is known about therapy dynamics and drivers of treatment choice. Particularly in China, a high emphasis on efficacy as well as cost leads to continued use of inexpensive, but suboptimal treatment approaches. For this report, 180 high-prescribing physicians where surveyed in these countries, providing a breakdown of patients numbers, frequently prescribed regimens and brand perceptions.

Published By Datamonitor
15 Feb 2010 $15200
Buy
Report
Report

Stakeholder Insight: Major Depressive Disorder - Gaining traction among physicians is crucial in an SSRI-dominated market

Primary research-based analysis of the major depressive disorder market, based on a survey of 180 psychiatrists in the US, Japan, and EU. Includes epidemiology, patient segmentation, treatment trends, perception of key brands, and patient outcomes.

Published By Datamonitor
23 Dec 2010 $15200
Buy

« | ... | 41 | 42 | 43 | 44 | 45 | 46 | 47 | 48 | 49 | ... | » »|

No help is available.